Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity

European Journal of Endocrinology

Volumn 161, Issue 6, 2009, Pages 837-844

  Kanety, Hannah ^a   Hemi, Rina ^a   Ginsberg, Shira ^b,c   Pariente, Clara ^a   Yissachar, Eleanor ^a,d   Barhod, Ehud ^a,d   Funahashi, Tohru ^e   Laron, Zvi ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BAR ILAN UNIVERSITY   (Israel)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; LIPID; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; BODY FAT DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE RELEASE; FEMALE; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; LARON SYNDROME; LIPID BLOOD LEVEL; MALE; MOLECULAR WEIGHT; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ADIPONECTIN; ADOLESCENT; ADULT; CHILD, PRESCHOOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OBESITY; PROTEIN MULTIMERIZATION;

EID: 72949118657     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0419     Document Type: Article

References (61)

1. Laron Z, Pertzelan A & Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone - a new inborn error of metabolism? Israel Journal of Medical Sciences 1966 2 152-155.
2. Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. Journal of Clinical Endocrinology and Metabolism 2004 89 1031-1044.
3. Rosenfeld RG, Rosenbloom AL & Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews 1994 15 369-390.
4. SavageMO, Attie KM, David A, Metherell LA, Clark AJ & Camacho-Hubner C. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nature Clinical Practice. Endocrinology & Metabolism 2006 2 395-407.
5. Shevah O & Laron Z. Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron syndrome. Pediatric Endocrinology Reviews 2006 3 489-497.
6. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z & Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. PNAS 1989 86 8083-8087.
7. Amselem S, Duquesnoy P, Duriez B, Dastot F, Sobrier ML, Valleix S & Goossens M. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Human Molecular Genetics 1993 2 355-359.
8. Shevah O, Rubinstein M & Laron Z. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups. Israel Medical Association Journal 2004 6 630-633.
9. Laron Z. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity). Pediatric Endocrinology Reviews 2008 5 766-771.
10. Laron Z, Pertzelan A & Karp M. Pituitary dwarfism with high serum levels of growth hormone. Israel Journal of Medical Sciences 1968 4 883-894.
11. Laron Z & Klinger B. Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. Hormone Research 1993 40 16-22.
12. Laron Z, Ginsberg S, Lilos P, Arbiv M & Vaisman N. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clinical Endocrinology 2006 65 114-117.
13. Laron Z, Klinger B, Grunebaum M, Feingold M & Tunnessen WW. Picture of the month. Laron-type dwarfism. American Journal of Diseases and Children 1991 145 473-474.
14. Laron Z, Ginsberg S, Lilos P, Arbiv M & Vaisman N. Long-term IGF-I treatment of children with Laron syndrome increases adiposity. Growth Hormone & IGF Research 2006 16 61-64.
15. Laron Z, Ginsberg S &Webb M. Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. Growth Hormone & IGF Research 2008 18 434-438.
16. Kadowaki T & Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 439-451.
17. Trujillo ME & Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocrine Reviews 2006 27 762-778.
18. Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R & Kanety H. Adiponectin in human cord blood: relation to fetal birth weight and gender. Journal of Clinical Endocrinology and Metabolism 2003 88 5656-5660.
19. Iniguez G, Soto N, Avila A, Salazar T, Ong K, Dunger D & Mericq V. Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5500-5503.
20. Tsai PJ, Yu CH, Hsu SP, Lee YH, Chiou CH, Hsu YW, Ho SC & Chu CH. Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity. Clinical Endocrinology 2004 61 88-93.
21. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M & Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. Journal of Clinical Endocrinology and Metabolism 2004 89 4053-4061.
22. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T & Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
23. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y & Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. Journal of Clinical Endocrinology and Metabolism 2002 87 4652-4656.
24. Kern PA, Di Gregorio GB, Lu T, Rassouli N & Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003 52 1779-1785.
25. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM & Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003 26 2383-2388.
26. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF & Patsch JR. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. European Journal of Clinical Investigation 2008 38 827-834.
27. Schraw T, Wang ZV, Halberg N, Hawkins M & Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 2008 149 2270-2282.
28. Wang Y, Lam KS, Yau MH & Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochemical Journal 2008 409 623-633.
29. Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M, Loewenthal R, Yissachar E, Hemi R & Kanety H. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. Journal of Clinical Endocrinology and Metabolism 2007 92 1843-1847.
30. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, Okada T, Nakagawa Y, Tamba S, Kuroda Y, Hayashi N, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Funahashi T & Matsuzawa Y. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circulation Journal 2008 72 23-28.
31. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R & Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry 2003 278 40352-40363.
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
33. Ginsberg S, Laron Z, Arbiv Bed M & Vaisman N. The obesity of patients with Laron syndrome is not associated with excessive nutritional intake. Obesity Research & Clinical Practice 2009 3 3-8.
34. Pinhas-Hamiel O, Singer S, Pilpel N, Koren I, Boyko V, Hemi R, Pariente C & Kanety H. Adiponectin levels in adolescent girls with polycystic ovary syndrome. Clinical Endocrinology, 2009. In Press. DOI: 10.1111/j.1365-2265.2009.03604.x.
35. Shand BI, Scott RS, Elder PA & George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes, Obesity & Metabolism 2003 5 349-353.
36. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW & Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. New England Journal of Medicine 2004 350 2549-2557.
37. Carrasco F, Ruz M, Rojas P, Csendes A, Rebolledo A, Codoceo J, Inostroza J, Basfi-Fer K, Papapietro K, Rojas J, Pizarro F & Olivares M. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obesity Surgery 2009 19 41-46.
38. Caixas A, Gimenez-Palop O, Gimenez-Perez G, Potau N, Berlanga E, Gonzalez-Glemente JM, Arroyo J, Laferrere B & Mauricio D. Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome. Hormone Research 2006 65 39-45.
39. Polak J, Kovacova Z, Holst C, Verdich C, Astrup A, Blaak E, Patel K, Oppert JM, Langin D, Martinez JA, Sorensen TI & Stich V. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. European Journal of Endocrinology 2008 158 533-541.
40. Butte NF, Comuzzie AG, Cai G, Cole SA, Mehta NR & Bacino CA. Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children. Journal of Clinical Endocrinology and Metabolism 2005 90 4170-4176.
41. Nassis GP, Papantakou K, Skenderi K, Triandafillopoulou M, Kavouras SA, Yannakoulia M, Chrousos GP & Sidossis LS. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism 2005 54 1472-1479.
42. Quiros-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW & Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. Journal of Pediatric Gastroenterology and Nutrition 2007 44 228-236.
43. Koebnick C, Roberts CK, Shaibi GQ, Kelly LA, Lane CJ, Toledo-Corral CM, Davis JN, Ventura EE, Alexander K, Weigensberg MJ & Goran MI. Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta-cell function in overweight Hispanic adolescents. Hormone and Metabolic Research 2008 40 708-712.
44. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK & Kopchick JJ. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormone & IGF Research 2004 14 309-318.
45. Nilsson L, Binart N, Bohlooly YM, Bramnert M, Egecioglu E, Kindblom J, Kelly PA, Kopchick JJ, Ormandy CJ, Ling C & Billig H. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochemical and Biophysical Research Communications 2005 331 1120-1126.
46. Andersson B, Carlsson LM, Carlsson B, Albertsson-Wikland K & Bjarnason R. Decrease in adiponectin levels correlates to growth response in growth hormone-treated children. Hormone Research 2009 71 213-218.
47. Kanety H, Karasik A, Klinger B, Silbergeld A & Laron Z. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. Acta Endocrinologica 1993 128 144-149.
48. Kim HS, Ali O, Shim M, Lee KW, Vuguin P, Muzumdar R, Barzilai N & Cohen P. Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo. Pediatric Research 2007 61 159-164.
49. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y & Brichard SM. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochemical and Biophysical Research Communications 2001 288 1102-1107.
50. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R & Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. International Journal of Obesity 2006 30 382-387.
51. Hill DJ, Riley SC, Bassett NS & Waters MJ. Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. Journal of Clinical Endocrinology and Metabolism 1992 75 646-650.
52. Wang ZV, Schraw TD, Kim JY, Khan T, Rajala MW, Follenzi A & Scherer PE. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Molecular and Cellular Biology 2007 27 3716-3731.
53. Lara-Castro C, Luo N, Wallace P, Klein RL & Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006 55 249-259.
54. Taksali SE, Caprio S, Dziura J, Dufour S, Cali AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA & Weiss R. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008 57 367-371.
55. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A & Bloom SR. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. Journal of Clinical Endocrinology and Metabolism 2001 86 4330-4338.
56. Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, Hernandez M, Del Castillo D, Argiles JM & Salas-Salvado J. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. International Journal of Obesity and Related Metabolic Disorders 2002 26 652-658.
57. Vilarrasa N, Vendrell J, Sanchez-Santos R, Broch M, Megia A, Masdevall C, Gomez N, Soler J, Pujol J, Bettonica C, Aranda H & Gomez JM. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clinical Endocrinology 2007 67 679-686.
58. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B & Thorner MO. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 2007 56 1638-1646.
59. Wolf I, Kuchuck I & Kanety H. Adiponectin and ghrelin: new players in cancer cachexia and carcinogenesis. Obesity and Metabolism 2006 2 221-229.
60. Barb D,Williams CJ, Neuwirth AK & Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. American Journal of Clinical Nutrition 2007 86 S858-S866.
61. Shevah O & Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Hormone & IGF Research 2007 17 54-57.